Professional Documents
Culture Documents
Elc590 Informative Speech Template (110917)
Elc590 Informative Speech Template (110917)
Name: Ernie Najwa Najihah Binti Faidi Topic: The Long Term Complication Of Systemic
Lupus Erythematosus (SLE)
This exercise requires you to provide an outline for your informative speech by filling in the following
template.
In this exercise, you need to choose at least one chart(s) and/or graph(s) related to your topic. Describe the
important data (facts and figures) and the salient features of the data from the chosen chart(s) and/or
graph(s). You are also required to choose at least one article related to your topic. Select relevant
information from the chosen article(s) to provide some supporting information for the data.
Introduction
Introduce topic The Long Term Complication Of Systemic Lupus Erythematosus
Credibility I am interested in this topic and have done some research on it
Background of topic According to Lupus Foundation of America,16 000 number of new cases of
lupus reported each year. As in Malaysia, it is estimated that 30 40 from
every 100,000 people suffered from SLE.
Central Idea The awareness of SLE is still lacking among Malaysian even when SLE is
already known as life threatened disease worldwide.
Body
(Describing chart[s] and/or graph[s])
Description of data 1. Chart 1 : The highest number of reported SLE cases in Malaysia
was represented by Chinese
2. Chart 1 : Indian have higher rate of deceased of SLE patient
compared to the percentage of its survivors
3. Chart 1 : compared to Indian, Malay has higher reported cases of
SLE but has the same rate of the deceased and its survivors
4. Chart 2: SLE contribute 70% of forms of Lupus compared to
3. Renal disease affects about 30% of patients with SLE, and remains
the most dangerous, life-threatening complication.
4. Pleuritis, causing chest pain, cough and breathlessness, is the
most common pulmonary manifestation of SLE. Rarer
complications include interstitial lung disease and pulmonary
hypertension (both more common in systemic sclerosis) and
pulmonary haemorrhage.